Microbiota–Inflammasome Axis: Gut | April 2026

Introduction

The gastrointestinal tract functions as a highly integrated system where digestion, immunity, and metabolic regulation are closely linked to the gut microbiota. This vast microbial ecosystem plays a central role in maintaining mucosal integrity, immune balance, and systemic homeostasis. A key emerging regulator in this interaction is the inflammasome, a multiprotein complex that senses microbial and cellular danger signals and orchestrates innate immune responses. The microbiota–inflammasome axis has recently gained attention as a crucial bridge connecting gut health with systemic diseases, including cancer, metabolic disorders, and neurological conditions.

Problem Statement

Despite growing recognition of the microbiota’s role in disease, the precise mechanisms through which dysbiosis triggers pathological immune activation remain incompletely understood. In particular, the role of inflammasomes as central mediators of microbiota-driven inflammation is underexplored. This gap limits our ability to translate microbiome science into targeted therapies, especially in complex diseases such as inflammatory bowel disease, gastrointestinal cancers, and neuroinflammatory disorders.

Summary

This review highlights that dysbiosis can aberrantly activate inflammasomes, disrupting gut homeostasis and promoting chronic inflammation. The microbiota–inflammasome axis influences not only gastrointestinal diseases but also systemic conditions via pathways such as the gut–brain axis, including vagal signaling and neuroendocrine responses. Importantly, inflammasome-mediated cytokines act as key messengers linking gut-derived signals to distant organs. Emerging evidence also demonstrates a role in cancer progression and immune modulation. The integration of artificial intelligence is accelerating understanding of these complex interactions, enabling biomarker discovery and therapeutic targeting. Overall, the microbiota–inflammasome axis represents a promising frontier for precision medicine across gastrointestinal and systemic diseases.